Literature DB >> 7500755

Severe septic shock unresponsive to noradrenaline.

G M Wray1, J H Coakley.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7500755     DOI： 10.1016/s0140-6736(95)91933-3

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  12 in total

1.  Angiotensin for septic shock unresponsive to noradrenaline.

Authors:  M Yunge; A Petros
Journal:  Arch Dis Child       Date:  2000-05       Impact factor: 3.791

Review 2.  Tumor necrosis factor-α: regulation of renal function and blood pressure.

Authors:  Vanesa D Ramseyer; Jeffrey L Garvin
Journal:  Am J Physiol Renal Physiol       Date:  2013-03-20

Review 3.  Angiotensin II in septic shock.

Authors:  Thiago D Corrêa; Jukka Takala; Stephan M Jakob
Journal:  Crit Care       Date:  2015-03-16       Impact factor: 9.097

Review 4.  The effect of angiotensin II on blood pressure in patients with circulatory shock: a structured review of the literature.

Authors:  Laurence W Busse; Michael T McCurdy; Osman Ali; Anna Hall; Huaizhen Chen; Marlies Ostermann
Journal:  Crit Care       Date:  2017-12-28       Impact factor: 9.097

5.  Angiotensin II in vasodilatory shock: lights and shadows.

Authors:  Elio Antonucci; Sara Agosta; Yasser Sakr
Journal:  Crit Care       Date:  2017-11-14       Impact factor: 9.097

Review 6.  Clinical Experience With IV Angiotensin II Administration: A Systematic Review of Safety.

Authors:  Laurence W Busse; Xueyuan Shelly Wang; Divya M Chalikonda; Kevin W Finkel; Ashish K Khanna; Harold M Szerlip; David Yoo; Sharon L Dana; Lakhmir S Chawla
Journal:  Crit Care Med       Date:  2017-08       Impact factor: 7.598

7.  Outcomes in Patients with Vasodilatory Shock and Renal Replacement Therapy Treated with Intravenous Angiotensin II.

Authors:  James A Tumlin; Raghavan Murugan; Adam M Deane; Marlies Ostermann; Laurence W Busse; Kealy R Ham; Kianoush Kashani; Harold M Szerlip; John R Prowle; Azra Bihorac; Kevin W Finkel; Alexander Zarbock; Lui G Forni; Shannan J Lynch; Jeff Jensen; Stew Kroll; Lakhmir S Chawla; George F Tidmarsh; Rinaldo Bellomo
Journal:  Crit Care Med       Date:  2018-06       Impact factor: 7.598

8.  Angiotensin II in experimental hyperdynamic sepsis.

Authors:  Li Wan; Christoph Langenberg; Rinaldo Bellomo; Clive N May
Journal:  Crit Care       Date:  2009-11-30       Impact factor: 9.097

9.  Intravenous angiotensin II for the treatment of high-output shock (ATHOS trial): a pilot study.

Authors:  Lakhmir S Chawla; Laurence Busse; Ermira Brasha-Mitchell; Danielle Davison; Jacqueline Honiq; Ziyad Alotaibi; Michael G Seneff
Journal:  Crit Care       Date:  2014-10-06       Impact factor: 9.097

Review 10.  Angiotensin in Critical Care.

Authors:  Anna Hall; Laurence W Busse; Marlies Ostermann
Journal:  Crit Care       Date:  2018-03-20       Impact factor: 9.097
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.